December 16 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Wednesday that its CEO Ognyan Donev acquired 32,854 shares in the company at a weighted average price of 3.16 levs ($1.97/1.62 euro) on December 15.